Adriana Cruvinel‐Carloni

The prognostic impact of <i>TERT</i> promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism

Rui Batısta, Adriana Cruvinel‐Carloni, João Vinagre et al. · International Journal of Cancer · 2016 · 58 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Cytotoxicity of allitinib, an irreversible anti-EGFR agent, in a large panel of human cancer-derived cell lines: KRAS mutation status as a predictive biomarker

Renato José da Silva Oliveira, Viviane Aline Oliveira Silva, Olga Martinho et al. · Cellular Oncology · 2016 · 45 citations · Full text

Medicine, Oncology, Pharmacology +14

TERT Promoter Mutation C228T Increases Risk for Tumor Recurrence and Death in Head and Neck Cancer Patients

Lídia Maria Rebolho Batista Arantes, Adriana Cruvinel‐Carloni, Ana Carolina de Carvalho et al. · Frontiers in Oncology · 2020 · 28 citations · Full text

Medicine, Molecular Genetics, Oncology +15

PIK3CA mutations are frequent in esophageal squamous cell carcinoma associated with chagasic megaesophagus and are associated with a worse patient outcome

Fernanda Franco Munari, Adriana Cruvinel‐Carloni, Croider Franco Lacerda et al. · Infectious Agents and Cancer · 2018 · 19 citations · Full text

Medicine, Genetics, Oncology +17

<i>TERT</i> Promoter Mutations in Soft Tissue Sarcomas

Nathália C. Campanella, Valter Penna, Lucas Faria Abrahão‐Machado et al. · The International Journal of Biological Markers · 2015 · 16 citations · Full text

Medicine, Genetics, Molecular Genetics +13